The Drug Enforcement Administration this week proposed changing rules that govern the amount of prescription opioids that drug manufacturers can produce each year. The changes could sharply reduce the annual production of opioids, Reuters reports.
The acting chief of the Drug Enforcement Administration told the House Energy and Committee this week the agency is doing a better job of tracking the flow of opioid painkillers from manufacturers to pharmacies, The Washington Post reports.
The Drug Enforcement Administration will classify illicit versions of fentanyl at the same level as heroin, Reuters reports. The action will make it easier for federal prosecutors and agents to prosecute traffickers of all forms of fentanyl-related substances, the agency said.
Chuck Rosenberg, the acting head of the Drug Enforcement Administration, said he will resign at the end of the week, The New York Times reports. Law enforcement officials said Rosenberg has grown disillusioned with President Trump and feels he has little respect for the law.
Two major drug wholesalers recently agreed to pay millions of dollars to settle claims they failed to report suspicious orders for opioid painkillers to the Drug Enforcement Administration, according to NPR.
The head of the Drug Enforcement Administration is visiting China this week to discuss combating sales of synthetic drugs, including fentanyl, CNN reports. Acting Administrator Chuck Rosenberg will also discuss new psychoactive substances and money-laundering activities when he meets with Chinese officials.
In the past year, federal and state policymakers have taken a number of steps to combat synthetic drugs, also known as “novel psychoactive substances,” according to Jonathan Woodruff, Senior Legislative Attorney at the National Alliance for Model State Drug Laws.
The Drug Enforcement Administration has temporarily banned the synthetic drug Pink under federal law, according to NBC News. The agency has received reports of at least 46 confirmed deaths associated with the drug.
Thirteen drug distribution companies knew or should have known that hundreds of millions of prescription narcotic pills were ending up on the black market, according to an investigation by The Washington Post.
The Drug Enforcement Administration said this week it will reverse its decision to temporarily make kratom a Schedule I drug, NPR reports. The reversal comes in the wake of protests by advocates, scientists and kratom vendors.
The Drug Enforcement Administration this week announced it is requiring significant cuts in the production of prescription opioids, HealthDay reports. By 2017 the amount of prescription opioids permitted to be manufactured in the U.S. will decrease by at least 25 percent.
The Drug Enforcement Administration has issued a warning to the public and law enforcement about the risks of the synthetic opioid carfentanil, ABC News reports. Carfentanil is 10,000 times more potent than morphine and 100 times more potent than fentanyl.
The Drug Enforcement Administration (DEA) on Thursday announced that it will not reclassify marijuana as a drug with accepted medical uses. The DEA will increase the number of authorized marijuana manufacturers supplying researchers.